Objectives: The article gives an review about hyperkinetic and conduct disorders in childhood and adolescence. After a summary of empirical results concerning symptoms and prevalence as well as comorbid disorders, concepts of releasing and maintaining factors are discussed. After a short description of assessment and monitoring, an overview on behavioural interventions, their indication and efficacy is given. Conclusions: Both disorders are frequent and they often coincide. In hyperkinetic disorders genetic factors are more important than in the development of conduct disorders. A comprehensive multimodal treatment is usually necessary. Pharmacotherapy is important in the treatment of hyperkinetic disorders. The effects of comprehensive behavioural interventions especially of parent trainings and interventions in the family and the schools are well established. In child-oriented interventions (e.g. self-instructional training, problem solving training, social skills training) particularly the transfer of treatment effects to the natural environment of the child (family, school, peers) has to be focused on.

This content is only available via PDF.
© 2000 S. Karger GmbH, Freiburg
2000
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.